Kymera Therapeutics
Price & Volume
Stats
See moreOpen | $112.01 |
Previous Close | $112.08 |
Day Range | $109.02-$112.06 |
52W Range | $55.26-$130.05 |
Market Cap | $9.3B |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $105M |
Revenue Growth (YoY) | 466.4% |
Gross Profit (12 Mos) | -$270.5M |
Diluted EPS | -$3.25 |
News
See moreYahoo Finance • 9 days ago
13 High-Conviction & Catalyst-Driven Long Ideas for 4Q 2026
Yahoo Finance • last month
Kymera's KT-621 Has 'Oral Dupixent' Potential, but Valuation Limits Upside, RBC Says
Yahoo Finance • 2 months ago
Kymera Therapeutics (KYMR) Q2 2026 Earnings Call Transcript
Yahoo Finance • 2 months ago
Kymera Therapeutics Q2 Earnings Call Highlights
About
CEO | Dr. Nello Mainolfi M.D., Ph.D. |
Address | 500 North Beacon Street, Watertown, MA, United States, 02472 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 273 |